Dominick Colangelo Named CEO Of Aastrom Biosciences
ANN ARBOR - Aastrom Biosciences Inc. announced Wednesday that it has named Dominick Colangelo president and CEO. Dan Orlando, who had been interim CEO of Aastrom since November, will continue as chief commercial officer. Orlando replaced had replaced Tim Mayleben. Colangelo has more than 20 years of experience in the pharmaceutical industry, including almost 10